Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > if no financing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ForexWhaleon Dec 19, 2018 10:36pm
41 Views
Post# 29138669

RE:RE:RE:RE:if no financing

RE:RE:RE:RE:if no financing Its a 5 million dollar worth company with no staff I am guessing who can reply to every email. Usually companies have PR departments and CEO is not responding directly as it can be agains the law as well for a public company.

Bashers will always find a way to talk this down. Fact is that they are reviewing quotes and thats about it. Presentation is being updated as well. My guess is they will update it with new partner name and its offline as they are not seeking quotes anymore.

Anyways. We can argue here all day and gain nothing. All the best with your strategy but I was and will stay long on this one purely based on latest NR's. My hope is to have a licensing out deal rather than just 2 million funding at 5 cents.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities